IDEXX 實驗室有限公司
DE ˙ XTRA ˙ US45168D1046
€490.30 ↑19.90 (4.23%)
2026-06-04
分享價格
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionIntegrated Wealth Concepts LLC
Latest Disclosed Ownership11,339 shares
Latest Disclosed Value $ 6,371,090
Integrated Wealth Concepts LLC reports 2,939.95% increase in ownership of IX1 / IDEXX Laboratories, Inc.

On May 15, 2026 - Integrated Wealth Concepts LLC filed a 13F-HR form disclosing ownership of 11,339 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $5,533,432 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 373 shares of IDEXX Laboratories, Inc.. This represents a change in shares of 2,939.95% during the quarter. The current value of the position is $5,559,512 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IDEXX LABS Common Stock 45168D104 11,339 10,966 2,939.95 6,371 2,428.17 0.0508
2026-02-13 2025-12-31 13F IDEXX LABS Common Stock 45168D104 373 -12,730 -97.15 253 -96.99 0.0030
2025-11-14 2025-09-30 13F IDEXX LABS Common Stock 45168D104 13,103 -1,542 -10.53 8,371 6.58 0.0749
2025-08-14 2025-06-30 13F IDEXX LABS Common Stock 45168D104 14,645 4,862 49.70 7,855 91.19 0.0788
2025-05-15 2025-03-31 13F IDEXX LABS Common Stock 45168D104 9,783 73 0.75 4,109 2.34 0.0479
2025-02-14 2024-12-31 13F IDEXX LABS Common Stock 45168D104 9,710 9,710 4,015 0.0466
2022-05-12 2022-03-31 13F IDEXX LABS Common Stock 45168D104 0 -322 -100.00 0 -100.00
2022-02-15 2021-12-31 13F IDEXX LABS Common Stock 45168D104 322 322 212 0.0063
2021-11-15 2021-09-30 13F IDEXX LABS Common Stock 45168D104 0 -701 -100.00 0 -100.00
2021-08-13 2021-06-30 13F IDEXX LABS Common Stock 45168D104 701 -15 -2.09 443 26.57 0.0157
2021-05-13 2021-03-31 13F IDEXX LABS Common Stock 45168D104 716 82 12.93 350 10.41 0.0144
2021-02-12 2020-12-31 13F IDEXX LABS Common Stock 45168D104 634 35 5.84 317 34.89 0.0150
2020-11-13 2020-09-30 13F IDEXX LABS Common Stock 45168D104 599 599 235 0.0145
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.